SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (89)2/16/2000 10:13:00 AM
From: Dave K  Read Replies (1) of 1833
 
>> what does everyone include in their valuation models for royalties? I have $24 million for 2006, assigning $0 to SmithKline <<

Rick, what's your breakdown ? I've been assuming Smithkline was out of the picture ? However your reference to them reminded me that I recall seeing mentioned that Cadus delivered (9 ?) targets to them (in 1998 ?). Is this where royalties are expected assuming SKB development proceeds ?

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext